USPTO serial 87140221
PARSORTIX
Reviewed by CopyMark Law Group
- Filing date
- Status date
- Registration date
- Mar 20, 2018
- Examiner
- LEE, IN PYO
- Law office
- PUBLICATION AND ISSUE SECTION
What this means
Status 704 applies to Madrid Protocol extensions of protection in the U.S. Section 71 (similar to Section 8) showing continued use was accepted. The U.S. extension remains active. Follow Madrid and USPTO deadlines for the next renewal cycle.
Need help with PARSORTIX?
If you own this trademark, we can monitor new filings and help with USPTO deadlines. If you do not, we can file a new U.S. application.
Current trademark owner
Monitor this mark, or talk with CopyMark about this registration.
Not the owner?
File a new U.S. trademark application, or speak with our attorneys.
Owner
GUILDFORD, GB
Guildford, Surrey, GB
Guildford, Surrey, GB
Guildford, Surrey, GB
Attorney of record
The USPTO lists this attorney as the applicant's representative for correspondence on this application.
Christina M. Licursi
Christina M. Licursi WOLF, GREENFIELD & SACKS, P.C.600 ATLANTIC AVENUEBOSTON, MA 02210-2206United StatesGoods and services
| Class | Description | Status | First use |
|---|---|---|---|
| 001 | [ Diagnostic preparations and reagents for scientific or research use; Chemical reagents for non-medical purposes; reagents for in vitro use for scientific or medical research; buffer solutions and reagents for use in diagnostic analysis and research with laboratory apparatus, namely, separation apparatus and analysis apparatus; biomarkers, namely, nucleic acid, protein and other biochemical ligands for scientific or research use; diagnostic kits comprised of diagnostic reagents and assay components for clinical and medical laboratory use ] | SECTION 8 - CANCELLED | — |
| 005 | [ Medical diagnostic reagents and assay components for testing of body fluids including blood and plasma, and cells; medical diagnostic kits comprised of diagnostic reagents and assay components for testing of body fluids including blood and plasma, and cells for medical purposes; all the aforesaid goods not including any such goods that are prescription only pharmaceuticals; biomarkers, namely, diagnostic biomarker reagents for medical purposes; diagnostic reagent kits consisting primarily of medical diagnostic reagents and assays, for use in detecting cancerous conditions and other conditions involving somatic genetic changes; medical testing kits comprising reagents to assay biochemicals including nucleic acids and proteins, for use in detecting cancerous conditions and other conditions involving somatic genetic changes for medical purposes ] | SECTION 8 - CANCELLED | — |
| 009 | Apparatus, equipment and instruments for scientific, laboratory, diagnostic or general research use, namely, laboratory vessels, analyzers, pre-packed columns for use in separation and purification, glassware, tubes including sample tubes, reagent tubes; [ phlebotomy tubes and eppendorf tubes; ] apparatus, equipment and instruments for cytology, histology and for use in detecting cancerous conditions for laboratory or research use; apparatus in the nature of cassettes for use in laboratory, diagnostic or general research use; cell analyzer providing quantitative cell analysis for scientific, laboratory or general research use and disposable cassettes therefor; apparatus for use in testing and analyzing blood and blood cells for laboratory or research use; [ biological analysis computer software; ] parts and fitting for the aforesaid goods; medical laboratory research instruments for use in the detection of cancer | ACTIVE | — |
| 010 | [ Medical diagnostic apparatus, equipment and instruments for diagnosis of clinical conditions involving the presence of solid tissue cells in blood; ] medical testing apparatus, equipment and instruments, namely, medical diagnostic apparatus for testing body fluids including blood and plasma, cancer cells; [ fetal cells; ] parts and fittings for the aforesaid goods; diagnostic apparatus, equipment and instruments for cytology and histology, all for use in detecting cancer | ACTIVE | — |
Related trademarks
CopyMark links this record to cited §2(d) serials, the owner's other marks, Nice classes, similar mark names, and recently changed USPTO applications.
- Other trademarks owned by CELLBXHEALTH EUROPE LIMITED
- Other trademarks owned by Angle Europe Limited
- Other trademarks owned by Angle Europe Limited
- Other trademarks owned by Angle Europe Limited
- Other trademarks in Class 001
- Other trademarks in Class 005
- Other trademarks in Class 009
- Other trademarks in Class 010
- Similar marks named PARSORTIX
- Recently changed USPTO trademarks
- Recently filed trademarks
- Browse all trademark records
Prosecution history
| Date | Code | Event | What it means |
|---|---|---|---|
| May 13, 2026 | ASGN | AUTOMATIC UPDATE OF ASSIGNMENT OF OWNERSHIP | — |
| Mar 28, 2025 | NAS8 | NOTICE OF ACCEPTANCE OF SEC. 8 - E-MAILED | — |
| Mar 28, 2025 | 8.PR | REGISTERED - PARTIAL SEC. 8 (6-YR) ACCEPTED | — |
| Mar 28, 2025 | APRE | CASE ASSIGNED TO POST REGISTRATION PARALEGAL | — |
| Aug 22, 2024 | ES8R | TEAS SECTION 8 RECEIVED | — |
| Mar 20, 2023 | REM1 | COURTESY REMINDER - SEC. 8 (6-YR) E-MAILED | — |
| Mar 20, 2018 | R.PR | REGISTERED-PRINCIPAL REGISTER | Your trademark is registered on the Principal Register — the strongest form of federal trademark protection. You may use the ® symbol for the covered goods and services. Maintenance filings (Section 8 and renewals) are required to keep the registration alive. |
| Jan 2, 2018 | NPUB | OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED | — |
| Jan 2, 2018 | PUBO | PUBLISHED FOR OPPOSITION | Your mark was published in the USPTO Official Gazette for a 30-day opposition window. During that period, third parties who believe they would be harmed can file an opposition. If no opposition is filed, prosecution usually continues toward registration or a Notice of Allowance. |
| Dec 13, 2017 | NONP | NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED | — |
| Nov 29, 2017 | PREV | LAW OFFICE PUBLICATION REVIEW COMPLETED | — |
| Nov 21, 2017 | CNSA | APPROVED FOR PUB - PRINCIPAL REGISTER | — |
| Nov 21, 2017 | XAEC | EXAMINER'S AMENDMENT ENTERED | — |
| Nov 21, 2017 | GNEN | NOTIFICATION OF EXAMINERS AMENDMENT E-MAILED | — |
| Nov 21, 2017 | GNEA | EXAMINERS AMENDMENT E-MAILED | — |
| Nov 21, 2017 | CNEA | EXAMINERS AMENDMENT -WRITTEN | — |
| Nov 14, 2017 | ZZZX | PREVIOUS ALLOWANCE COUNT WITHDRAWN | — |
| Nov 7, 2017 | PBCR | WITHDRAWN FROM PUB - OG REVIEW QUERY | — |
| Oct 26, 2017 | PREV | LAW OFFICE PUBLICATION REVIEW COMPLETED | — |
| Oct 17, 2017 | CNSA | APPROVED FOR PUB - PRINCIPAL REGISTER | — |
| Oct 16, 2017 | XAEC | EXAMINER'S AMENDMENT ENTERED | — |
| Oct 16, 2017 | GNEN | NOTIFICATION OF EXAMINERS AMENDMENT E-MAILED | — |
| Oct 16, 2017 | GNEA | EXAMINERS AMENDMENT E-MAILED | — |
| Oct 16, 2017 | CNEA | EXAMINERS AMENDMENT -WRITTEN | — |
| Oct 10, 2017 | ZZZX | PREVIOUS ALLOWANCE COUNT WITHDRAWN | — |
| Sep 26, 2017 | PBCR | WITHDRAWN FROM PUB - OG REVIEW QUERY | — |
| Sep 12, 2017 | CNSA | APPROVED FOR PUB - PRINCIPAL REGISTER | — |
| Sep 11, 2017 | XAEC | EXAMINER'S AMENDMENT ENTERED | — |
| Sep 11, 2017 | GNEN | NOTIFICATION OF EXAMINERS AMENDMENT E-MAILED | — |
| Sep 11, 2017 | GNEA | EXAMINERS AMENDMENT E-MAILED | — |
| Sep 11, 2017 | CNEA | EXAMINERS AMENDMENT -WRITTEN | — |
| Aug 23, 2017 | TEME | TEAS/EMAIL CORRESPONDENCE ENTERED | — |
| Aug 23, 2017 | CRFA | CORRESPONDENCE RECEIVED IN LAW OFFICE | — |
| Aug 22, 2017 | ALIE | ASSIGNED TO LIE | — |
| Aug 1, 2017 | TROA | TEAS RESPONSE TO OFFICE ACTION RECEIVED | This event means the applicant filed a response to a USPTO Office Action — typically arguments, amendments, or evidence addressing the examiner's objections. The USPTO will review the response and either allow the mark to proceed or issue another action. |
| Mar 7, 2017 | GNRN | NOTIFICATION OF NON-FINAL ACTION E-MAILED | A non-final Office Action means the USPTO examining attorney has raised at least one issue with your trademark application but has not made a final decision. You usually have three months to respond with arguments, amendments, or evidence. Missing the deadline can abandon the application. |
| Mar 7, 2017 | GNRT | NON-FINAL ACTION E-MAILED | A non-final Office Action means the USPTO examining attorney has raised at least one issue with your trademark application but has not made a final decision. You usually have three months to respond with arguments, amendments, or evidence. Missing the deadline can abandon the application. |
| Mar 7, 2017 | CNRT | NON-FINAL ACTION WRITTEN | A non-final Office Action means the USPTO examining attorney has raised at least one issue with your trademark application but has not made a final decision. You usually have three months to respond with arguments, amendments, or evidence. Missing the deadline can abandon the application. |
| Feb 11, 2017 | TEME | TEAS/EMAIL CORRESPONDENCE ENTERED | — |
| Feb 10, 2017 | CRFA | CORRESPONDENCE RECEIVED IN LAW OFFICE | — |
| Feb 10, 2017 | TROA | TEAS RESPONSE TO OFFICE ACTION RECEIVED | This event means the applicant filed a response to a USPTO Office Action — typically arguments, amendments, or evidence addressing the examiner's objections. The USPTO will review the response and either allow the mark to proceed or issue another action. |
| Dec 6, 2016 | GNRN | NOTIFICATION OF NON-FINAL ACTION E-MAILED | A non-final Office Action means the USPTO examining attorney has raised at least one issue with your trademark application but has not made a final decision. You usually have three months to respond with arguments, amendments, or evidence. Missing the deadline can abandon the application. |
| Dec 6, 2016 | GNRT | NON-FINAL ACTION E-MAILED | A non-final Office Action means the USPTO examining attorney has raised at least one issue with your trademark application but has not made a final decision. You usually have three months to respond with arguments, amendments, or evidence. Missing the deadline can abandon the application. |
| Dec 6, 2016 | CNRT | NON-FINAL ACTION WRITTEN | A non-final Office Action means the USPTO examining attorney has raised at least one issue with your trademark application but has not made a final decision. You usually have three months to respond with arguments, amendments, or evidence. Missing the deadline can abandon the application. |
| Nov 28, 2016 | DOCK | ASSIGNED TO EXAMINER | — |
| Aug 19, 2016 | NWOS | NEW APPLICATION OFFICE SUPPLIED DATA ENTERED | — |
| Aug 19, 2016 | NWAP | NEW APPLICATION ENTERED | — |